About Dual AAV
Dual AAV vectors split your gene into two vectors that under in-vivo homologous recombination, reforms to produce a full gene product. These are used when payloads >4.7kb are required.
Dual AAV vector controls contain two AAV vectors, with each vector carrying half of a GFP reporter gene. When recombined, a functional GFP is formed, allowing quick visual read-out.
Your team can use dual AAV vector controls to de-risk projects, for proof-of-principle studies, and to optimize parameters before moving into larger, more complex experiments. These controls are available in a wide range of promoters for tissue targeting.
Features
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
AAV-h-AMICA1-shRNA
Cat No: shAAV-200849
Availability: 6-8 weeks
AAV-h-AMIGO1-shRNA
Cat No: shAAV-200852
Availability: 6-8 weeks
AAV-h-AMIGO2-shRNA
Cat No: shAAV-200853
Availability: 4-5 weeks
AAV-h-AMIGO3-shRNA
Cat No: shAAV-200855
Availability: 6-8 weeks
AAV-h-AMMECR1-shRNA
Cat No: shAAV-200859
Availability: 4-5 weeks
AAV-h-AMMECR1L-shRNA
Cat No: shAAV-200860
Availability: 4-5 weeks
AAV-h-AMN1-shRNA
Cat No: shAAV-200864
Availability: 6-8 weeks
AAV-h-AMOT-shRNA
Cat No: shAAV-200865
Availability: 4-5 weeks
AAV-h-AMOTL1-shRNA
Cat No: shAAV-200866
Availability: 4-5 weeks
AAV-h-AMOTL2-shRNA
Cat No: shAAV-200867
Availability: 6-8 weeks
AAV-h-AMPD1-shRNA
Cat No: shAAV-200869
Availability: 6-8 weeks
AAV-h-AMPD2-shRNA
Cat No: shAAV-200870
Availability: 4-5 weeks
